Literature DB >> 9664098

A knockout of a transgenic mouse--animal models of sickle cell anemia.

R L Nagel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9664098     DOI： 10.1056/NEJM199807163390310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse.

Authors:  S H Embury; N Mohandas; C Paszty; P Cooper; A T Cheung
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Anthony J Croatt; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-27

4.  Melanoma tumor growth is accelerated in a mouse model of sickle cell disease.

Authors:  Jintao Wang; Jennifer Tran; Hui Wang; Wei Luo; Chiao Guo; David Harro; Andrew D Campbell; Daniel T Eitzman
Journal:  Exp Hematol Oncol       Date:  2015-07-07

5.  Cardiorespiratory pathogenesis of sickle cell disease in a mouse model.

Authors:  Jun Ren; Xiuqing Ding; Marie Trudel; John J Greer; Joanna E MacLean
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

6.  Sickle cell disease up-regulates vasopressin, aquaporin 2, urea transporter A1, Na-K-Cl cotransporter 2, and epithelial Na channels in the mouse kidney medulla despite compromising urinary concentration ability.

Authors:  Hong Wang; Ryan G Morris; Mark A Knepper; Xiaoming Zhou
Journal:  Physiol Rep       Date:  2019-04

Review 7.  Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia.

Authors:  Ngozi Awa Imaga
Journal:  ScientificWorldJournal       Date:  2013-02-14

8.  mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.

Authors:  Jintao Wang; Jennifer Tran; Hui Wang; Chiao Guo; David Harro; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2016-03-31       Impact factor: 8.615
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.